Short-term effects of combined treatment with potassium bromide and methimazole in patients with Graves' disease

Journal of Endocrinological Investigation

Volumn 35, Issue 11, 2012, Pages 971-974

  Li, D ^a   Pei, H ^a   Li, X ^a,b   Liu, X ^a   Xie, Y ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Graves' disease; Potassium bromide

Indexed keywords

METOPROLOL TARTRATE; PLACEBO; POTASSIUM BROMIDE; THIAMAZOLE; THYROID HORMONE;

ADULT; AMNESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DEPRESSION; DRUG MECHANISM; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MALE; RASH; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTITHYROID AGENTS; BROMIDES; DRUG THERAPY, COMBINATION; FEMALE; GRAVES DISEASE; HUMANS; MALE; METHIMAZOLE; POTASSIUM COMPOUNDS; THYROID HORMONES; YOUNG ADULT;

EID: 84871890397     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8188     Document Type: Article

References (16)

1. Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA 1995, 273: 808-12.
2. Abraham-Nordling M, Byström K, Törring O, et al. Incidence of Hyperthyroidism in Sweden. Eur J Endocrinol 2011, 165: 899-905.
3. Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993, 14: 747-93. (Pubitemid 24016660)
4. Schwartz KM, Fatourechi V, Ahmed DD, Pond GR. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab 2002, 87: 438-46. (Pubitemid 34158200)
5. Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA 1990, 263: 1529-32. (Pubitemid 20099049)
6. Patwardhan NA, Moroni M, Rao S, Rossi S, Braverman LE. Surgery still has a role in Graves' hyperthyroidism. Surgery 1993, 94: 1108-12.
7. Cooper DS. Antithyroid drugs. N Engl J Med 1984, 39: 1353-62. (Pubitemid 15129606)
8. Korinthenberg R, Burkart P, Woelfle C, Moenting JS, Ernst JP. Pharmacology, efficacy, and tolerability of potassium bromide in childhood epilepsy. J Child Neurol 2007, 22: 414-8. (Pubitemid 46909528)
9. Pavelka S. Metabolism of bromide and its interference with the metabolism of iodine. Physiol Res 2004, 53 (Suppl 1): S81-90. (Pubitemid 38609628)
10. Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971, 12: 371-9.
11. Oguni H, Hayashi K, Oguni M, et al. Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant. Epilepsia 1994, 35: 940-5.
12. Homsanit M, Sriussadaporn S, Vannasaeng S, Peerapatdit T, Nitiyanant W, Vichayanrat A. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism. Clin Endocrinol (Oxf) 2001, 54: 385-90. (Pubitemid 32234204)
13. Kampman JP, Hansen JM. Clinical pharmacokinetics of antithyroid drugs. Clin Pharmacokin 1981, 6: 401-28. (Pubitemid 12213269)
14. Mashio Y, Beniko M, Ikota A, Mizumoto H, Kunita H. Treatment of hyperthyroidism wih a small single daily dose of methimazol. Acta Endocrinol (Copenh) 1988, 99: 139-44. (Pubitemid 18262659)
15. Brodie MJ. Antiepileptic drug therapy the story so far. Siezure 2010, 19: 650-5.
16. Velický J, Titlbach M, Dusková J, Vobecký M, Strbák V, Raska I. Potassium bromide and the thyroid gland of the rat: morphology and immunohistochemistry, RIA and INAA analysis. Ann Anat 1997, 179: 421-31. (Pubitemid 27470021)